Teladoc Inc  

(Public, NYSE:TDOC)   Watch this stock  
Find more results for TDOC
18.90
+0.15 (0.80%)
After Hours: 18.90 0.00 (0.00%)
Jan 24, 4:44PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range 18.30 - 19.15
52 week 9.08 - 19.49
Open 18.75
Vol / Avg. 712,043.00/604,655.00
Mkt cap 1.00B
P/E     -
Div/yield     -
EPS -2.18
Shares 52.85M
Beta     -
Inst. own 78%
Feb 28, 2017
Q4 2016 Teladoc Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Oct 27, 2016
Q3 2016 Teladoc Inc Earnings Call
Oct 27, 2016
Q3 2016 Teladoc Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin -91.94% -74.98%
Operating margin -88.67% -72.09%
EBITD margin - -65.80%
Return on average assets -46.18% -36.08%
Return on average equity -60.58% -101.90%
Employees 658 -
CDP Score - -

Address

2 Manhattanville Rd Ste 203
PURCHASE, NY 10577-2118
United States - Map
+1-203-6352002 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Teladoc, Inc., together with its subsidiaries, is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company operates through health services segment. Its solution connects its Members, with its over 3,000 board-certified physicians and behavioral health professionals who treat a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation. Its enterprise scale platform is offered for real-time sharing of clinical and non-clinical data in real time among the Teladoc constituents, which include Members, Providers, physician network operations center staff, nurses, SureScripts for electronic medication prescription writing, routing and fulfillment and health plans for claims processing, clinical summaries and clinical alerts.

Officers and directors

David B. Snow Jr. Independent Chairman of the Board
Age: 61
Bio & Compensation  - Reuters
Jason Gorevic President, Chief Executive Officer, Director
Age: 43
Bio & Compensation  - Reuters
Mark J. Hirschhorn Chief Financial Officer, Chief Operating Officer, Executive Vice President
Age: 52
Bio & Compensation  - Reuters
Gabriel R. Cappucci Senior Vice President, Chief Accounting Officer, Controller
Age: 52
Bio & Compensation  - Reuters
Michael H King Chief Sales Officer
Age: 52
Bio & Compensation  - Reuters
Adam C. Vandervoort Chief Legal Officer and Secretary
Age: 40
Bio & Compensation  - Reuters
Helen Darling Independent Director
Bio & Compensation  - Reuters
Martin R. Felsenthal Independent Director
Age: 46
Bio & Compensation  - Reuters
William H. Frist M.D. Independent Director
Bio & Compensation  - Reuters
Michael S. Goldstein CPA Independent Director
Age: 73
Bio & Compensation  - Reuters